Methodologic approaches to surveillance of HIV infection among blood donors. 1990

L R Petersen, and R Dodd, and T J Dondero
Centers for Disease Control, Center for Infectious Diseases, Division of HIV/AIDS, Atlanta, GA 30333.

Blood donors make up the largest group in the United States that is tested for human immunodeficiency virus, type 1 (HIV) antibody. The blood donor population is ideal for detecting and quantifying uncommon or unrecognized modes of HIV transmission in the general population because persons at known risk for HIV infection are excluded from donating blood. The national HIV surveillance program consists of a centralized computer database of information on all donations at selected American Red Cross blood centers, which together account for about a quarter of the blood supply, and all donations at 20 regional blood centers where seropositive blood donors are interviewed to evaluate their risk factors for HIV infection and to determine their epidemiologic characteristics and motives for donation. Trends in HIV prevalence and incidence within specific demographic subgroups are determined for first-time and repeat donors. Combining the trends with HIV-risk profile data from seropositive donors provides a rate for HIV seropositive donors with no identified risk. Epidemiologic and behavioral data from seropositive donors will help in the development and evaluation of future donor deferral strategies.

UI MeSH Term Description Entries
D011159 Population Surveillance Ongoing scrutiny of a population (general population, study population, target population, etc.), generally using methods distinguished by their practicability, uniformity, and frequently their rapidity, rather than by complete accuracy. Surveillance, Population
D001771 Blood Banks Centers for collecting, characterizing and storing blood or plasma. Bank, Blood,Banks, Blood,Blood Bank
D001782 Blood Donors Individuals supplying blood or blood components for transfer to histocompatible recipients. Blood Donor,Donor, Blood,Donors, Blood
D003627 Data Interpretation, Statistical Application of statistical procedures to analyze specific observed or assumed facts from a particular study. Data Analysis, Statistical,Data Interpretations, Statistical,Interpretation, Statistical Data,Statistical Data Analysis,Statistical Data Interpretation,Analyses, Statistical Data,Analysis, Statistical Data,Data Analyses, Statistical,Interpretations, Statistical Data,Statistical Data Analyses,Statistical Data Interpretations
D006679 HIV Seropositivity Development of neutralizing antibodies in individuals who have been exposed to the human immunodeficiency virus (HIV/HTLV-III/LAV). AIDS Seroconversion,AIDS Seropositivity,Anti-HIV Positivity,HIV Antibody Positivity,HIV Seroconversion,HTLV-III Seroconversion,HTLV-III Seropositivity,AIDS Seroconversions,AIDS Seropositivities,Anti HIV Positivity,Anti-HIV Positivities,Antibody Positivities, HIV,Antibody Positivity, HIV,HIV Antibody Positivities,HIV Seroconversions,HIV Seropositivities,HTLV III Seroconversion,HTLV III Seropositivity,HTLV-III Seroconversions,HTLV-III Seropositivities,Positivities, Anti-HIV,Positivities, HIV Antibody,Positivity, Anti-HIV,Positivity, HIV Antibody,Seroconversion, AIDS,Seroconversion, HIV,Seroconversion, HTLV-III,Seroconversions, AIDS,Seroconversions, HIV,Seroconversions, HTLV-III,Seropositivities, AIDS,Seropositivities, HIV,Seropositivities, HTLV-III,Seropositivity, AIDS,Seropositivity, HIV,Seropositivity, HTLV-III
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D014481 United States A country in NORTH AMERICA between CANADA and MEXICO.
D015528 HIV Seroprevalence Studies of the number of cases where human immunodeficiency virus (HIV) is present in a specific population at a designated time. The presence in a given individual is determined by the finding of HIV antibodies in the serum (HIV SEROPOSITIVITY). Seroprevalence, HIV
D015994 Incidence The number of new cases of a given disease during a given period in a specified population. It also is used for the rate at which new events occur in a defined population. It is differentiated from PREVALENCE, which refers to all cases in the population at a given time. Attack Rate,Cumulative Incidence,Incidence Proportion,Incidence Rate,Person-time Rate,Secondary Attack Rate,Attack Rate, Secondary,Attack Rates,Cumulative Incidences,Incidence Proportions,Incidence Rates,Incidence, Cumulative,Incidences,Person time Rate,Person-time Rates,Proportion, Incidence,Rate, Attack,Rate, Incidence,Rate, Person-time,Rate, Secondary Attack,Secondary Attack Rates

Related Publications

L R Petersen, and R Dodd, and T J Dondero
October 1991, JPMA. The Journal of the Pakistan Medical Association,
L R Petersen, and R Dodd, and T J Dondero
January 2012, Revista brasileira de hematologia e hemoterapia,
L R Petersen, and R Dodd, and T J Dondero
November 1990, MMWR. Morbidity and mortality weekly report,
L R Petersen, and R Dodd, and T J Dondero
November 1992, European journal of epidemiology,
L R Petersen, and R Dodd, and T J Dondero
January 2005, Nigerian journal of medicine : journal of the National Association of Resident Doctors of Nigeria,
L R Petersen, and R Dodd, and T J Dondero
May 1994, The Indian journal of medical research,
L R Petersen, and R Dodd, and T J Dondero
August 2012, Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz,
L R Petersen, and R Dodd, and T J Dondero
March 1991, Releve epidemiologique hebdomadaire,
L R Petersen, and R Dodd, and T J Dondero
February 2006, AIDS (London, England),
Copied contents to your clipboard!